Aug. 31, 2019

There are many occasions in diabetes history when the experts are either wrong or take too long to recognize what is logically correct. A good example of this is back in the 70’s when the ADA stated, paraphrasing here, “The thought that someone could check their glucose, count their carbs and dose their insulin was ludicrous and would never occur.” Another has to do with the medication metformin, which was approved in most every country in the world in 1957 — but the FDA did not approve it till 1995.

The FDA has just done it again, with their decision to turn down dapagliflozin an indication for use in type 1 diabetes. This week our Intern, Kassey James, Pharm.D. Candidate, LECOM School of Pharmacy, has a special feature on why the FDA rejected the indication and how it goes smack against what tons of prescribers do.

 

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief